Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Catherine J Reynolds, Corinna Pade, Joseph M Gibbons, David K Butler, Ashley D Otter, Katia Menacho, Marianna Fontana, Angelique Smit, Jane E Sackville-West, Teresa Cutino-Moguel, Mala K Maini, Benjamin Chain, Mahdad Noursadeghi, UK COVIDsortium Immune Correlates Network, Tim Brooks, Amanda Semper, Charlotte Manisty, Thomas A Treibel, James C Moon, UK COVIDsortium Investigators, Ana M Valdes, Áine McKnight, Daniel M Altmann, Rosemary Boyton, Hakam Abbass, Mashael Alfarih, Zoe Alldis, Daniel M Altmann, Oliver E Amin, Mervyn Andiapen, Jessica Artico, João B Augusto, Georgina L Baca, Sasha N L Bailey, Anish N Bhuva, Alex Boulter, Ruth Bowles, Rosemary J Boyton, Olivia V Bracken, Ben O'Brien, Tim Brooks, Natalie Bullock, David K Butler, Gabriella Captur, Nicola Champion, Carmen Chan, Aneesh Chandran, Jorge Couto de Sousa, Xose Couto-Parada, Teresa Cutino-Moguel, Rhodri H Davies, Brooke Douglas, Cecilia Di Genova, Keenan Dieobi-Anene, Mariana O Diniz, Anaya Ellis, Karen Feehan, Malcolm Finlay, Marianna Fontana, Nasim Forooghi, Joseph M Gibbons, Derek Gilroy, Matt Hamblin, Gabrielle Harker, Jacqueline Hewson, Lauren M Hickling, Aroon D Hingorani, Lee Howes, Ivie Itua, Victor Jardim, Wing-Yiu Jason Lee, Melaniepetra Jensen, Jessica Jones, Meleri Jones, George Joy, Vikas Kapil, Hibba Kurdi, Jonathan Lambourne, Kai-Min Lin, Sarah Louth, Mala K Maini, Vineela Mandadapu, Charlotte Manisty, Áine McKnight, Katia Menacho, Celina Mfuko, Oliver Mitchelmore, Christopher Moon, James C Moon, Sam M Murray, Mahdad Noursadeghi, Ashley Otter, Corinna Pade, Susana Palma, Ruth Parker, Kush Patel, Babita Pawarova, Steffen E Petersen, Brian Piniera, Franziska P Pieper, Lisa Rannigan, Alicja Rapala, Catherine J Reynolds, Amy Richards, Matthew Robathan, Joshua Rosenheim, Genine Sambile, Nathalie M Schmidt, Amanda Semper, Andreas Seraphim, Mihaela Simion, Angelique Smit, Michelle Sugimoto, Leo Swadling, Stephen Taylor, Nigel Temperton, Stephen Thomas, George D Thornton, Thomas A Treibel, Art Tucker, Jessry Veerapen, Mohit Vijayakumar, Sophie Welch, Theresa Wodehouse, Lucinda Wynne, Dan Zahedi, Benjamin Chain, Catherine J Reynolds, Corinna Pade, Joseph M Gibbons, David K Butler, Ashley D Otter, Katia Menacho, Marianna Fontana, Angelique Smit, Jane E Sackville-West, Teresa Cutino-Moguel, Mala K Maini, Benjamin Chain, Mahdad Noursadeghi, UK COVIDsortium Immune Correlates Network, Tim Brooks, Amanda Semper, Charlotte Manisty, Thomas A Treibel, James C Moon, UK COVIDsortium Investigators, Ana M Valdes, Áine McKnight, Daniel M Altmann, Rosemary Boyton, Hakam Abbass, Mashael Alfarih, Zoe Alldis, Daniel M Altmann, Oliver E Amin, Mervyn Andiapen, Jessica Artico, João B Augusto, Georgina L Baca, Sasha N L Bailey, Anish N Bhuva, Alex Boulter, Ruth Bowles, Rosemary J Boyton, Olivia V Bracken, Ben O'Brien, Tim Brooks, Natalie Bullock, David K Butler, Gabriella Captur, Nicola Champion, Carmen Chan, Aneesh Chandran, Jorge Couto de Sousa, Xose Couto-Parada, Teresa Cutino-Moguel, Rhodri H Davies, Brooke Douglas, Cecilia Di Genova, Keenan Dieobi-Anene, Mariana O Diniz, Anaya Ellis, Karen Feehan, Malcolm Finlay, Marianna Fontana, Nasim Forooghi, Joseph M Gibbons, Derek Gilroy, Matt Hamblin, Gabrielle Harker, Jacqueline Hewson, Lauren M Hickling, Aroon D Hingorani, Lee Howes, Ivie Itua, Victor Jardim, Wing-Yiu Jason Lee, Melaniepetra Jensen, Jessica Jones, Meleri Jones, George Joy, Vikas Kapil, Hibba Kurdi, Jonathan Lambourne, Kai-Min Lin, Sarah Louth, Mala K Maini, Vineela Mandadapu, Charlotte Manisty, Áine McKnight, Katia Menacho, Celina Mfuko, Oliver Mitchelmore, Christopher Moon, James C Moon, Sam M Murray, Mahdad Noursadeghi, Ashley Otter, Corinna Pade, Susana Palma, Ruth Parker, Kush Patel, Babita Pawarova, Steffen E Petersen, Brian Piniera, Franziska P Pieper, Lisa Rannigan, Alicja Rapala, Catherine J Reynolds, Amy Richards, Matthew Robathan, Joshua Rosenheim, Genine Sambile, Nathalie M Schmidt, Amanda Semper, Andreas Seraphim, Mihaela Simion, Angelique Smit, Michelle Sugimoto, Leo Swadling, Stephen Taylor, Nigel Temperton, Stephen Thomas, George D Thornton, Thomas A Treibel, Art Tucker, Jessry Veerapen, Mohit Vijayakumar, Sophie Welch, Theresa Wodehouse, Lucinda Wynne, Dan Zahedi, Benjamin Chain
Abstract
SARS-CoV-2 vaccine rollout has coincided with the spread of variants of concern. We investigated if single dose vaccination, with or without prior infection, confers cross protective immunity to variants. We analyzed T and B cell responses after first dose vaccination with the Pfizer/BioNTech mRNA vaccine BNT162b2 in healthcare workers (HCW) followed longitudinally, with or without prior Wuhan-Hu-1 SARS-CoV-2 infection. After one dose, individuals with prior infection showed enhanced T cell immunity, antibody secreting memory B cell response to spike and neutralizing antibodies effective against B.1.1.7 and B.1.351. By comparison, HCW receiving one vaccine dose without prior infection showed reduced immunity against variants. B.1.1.7 and B.1.351 spike mutations resulted in increased, abrogated or unchanged T cell responses depending on human leukocyte antigen (HLA) polymorphisms. Single dose vaccination with BNT162b2 in the context of prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).
Figures
References
- Polack F. P., Thomas S. J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J. L., Pérez Marc G., Moreira E. D., Zerbini C., Bailey R., Swanson K. A., Roychoudhury S., Koury K., Li P., Kalina W. V., Cooper D., Frenck R. W. Jr.., Hammitt L. L., Türeci Ö., Nell H., Schaefer A., Ünal S., Tresnan D. B., Mather S., Dormitzer P. R., Şahin U., Jansen K. U., Gruber W. C.; C4591001 Clinical Trial Group , Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020). 10.1056/NEJMoa2034577
- Mascola J. R., Graham B. S., Fauci A. S., SARS-CoV-2 viral variants—tackling a moving target. JAMA 325, 1261–1262 (2021). 10.1001/jama.2021.2088
- Altmann D. M., Boyton R. J., Beale R., Immunity to SARS-CoV-2 variants of concern. Science 371, 1103–1104 (2021). 10.1126/science.abg7404
- A. Rambaut, N. Loman, O. Pybus, W. Barclay, J. Barrett, A. Carabelli, T. Connor, T. Peacock, D. L. Robertson, E. Volz, on behalf of COVID-19 Genomics Consortium UK (CoG-UK), Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations, (2020); .
- Wang Z., Schmidt F., Weisblum Y., Muecksch F., Barnes C. O., Finkin S., Schaefer-Babajew D., Cipolla M., Gaebler C., Lieberman J. A., Oliveira T. Y., Yang Z., Abernathy M. E., Huey-Tubman K. E., Hurley A., Turroja M., West K. A., Gordon K., Millard K. G., Ramos V., Da Silva J., Xu J., Colbert R. A., Patel R., Dizon J., Unson-O’Brien C., Shimeliovich I., Gazumyan A., Caskey M., Bjorkman P. J., Casellas R., Hatziioannou T., Bieniasz P. D., Nussenzweig M. C., mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 592, 616–622 (2021). 10.1038/s41586-021-03324-6
- Collier D. A., De Marco A., Ferreira I. A. T. M., Meng B., Datir R. P., Walls A. C., Kemp S. A., Bassi J., Pinto D., Silacci-Fregni C., Bianchi S., Tortorici M. A., Bowen J., Culap K., Jaconi S., Cameroni E., Snell G., Pizzuto M. S., Pellanda A. F., Garzoni C., Riva A., Elmer A., Kingston N., Graves B., McCoy L. E., Smith K. G. C., Bradley J. R., Temperton N., Ceron-Gutierrez L., Barcenas-Morales G., Harvey W., Virgin H. W., Lanzavecchia A., Piccoli L., Doffinger R., Wills M., Veesler D., Corti D., Gupta R. K.; CITIID-NIHR BioResource COVID-19 Collaboration; COVID-19 Genomics UK (COG-UK) Consortium , Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature 593, 136–141 (2021). 10.1038/s41586-021-03412-7
- Walsh E. E., Frenck R. W. Jr.., Falsey A. R., Kitchin N., Absalon J., Gurtman A., Lockhart S., Neuzil K., Mulligan M. J., Bailey R., Swanson K. A., Li P., Koury K., Kalina W., Cooper D., Fontes-Garfias C., Shi P. Y., Türeci Ö., Tompkins K. R., Lyke K. E., Raabe V., Dormitzer P. R., Jansen K. U., Şahin U., Gruber W. C., Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N. Engl. J. Med. 383, 2439–2450 (2020). 10.1056/NEJMoa2027906
- Sahin U., Muik A., Derhovanessian E., Vogler I., Kranz L. M., Vormehr M., Baum A., Pascal K., Quandt J., Maurus D., Brachtendorf S., Lörks V., Sikorski J., Hilker R., Becker D., Eller A. K., Grützner J., Boesler C., Rosenbaum C., Kühnle M. C., Luxemburger U., Kemmer-Brück A., Langer D., Bexon M., Bolte S., Karikó K., Palanche T., Fischer B., Schultz A., Shi P. Y., Fontes-Garfias C., Perez J. L., Swanson K. A., Loschko J., Scully I. L., Cutler M., Kalina W., Kyratsous C. A., Cooper D., Dormitzer P. R., Jansen K. U., Türeci Ö., COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594–599 (2020). 10.1038/s41586-020-2814-7
- Treibel T. A., Manisty C., Burton M., McKnight Á., Lambourne J., Augusto J. B., Couto-Parada X., Cutino-Moguel T., Noursadeghi M., Moon J. C., COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet 395, 1608–1610 (2020). 10.1016/S0140-6736(20)31100-4
- Augusto J. B., Menacho K., Andiapen M., Bowles R., Burton M., Welch S., Bhuva A. N., Seraphim A., Pade C., Joy G., Jensen M., Davies R. H., Captur G., Fontana M., Montgomery H., O’Brien B., Hingorani A. D., Cutino-Moguel T., McKnight Á., Abbass H., Alfarih M., Alldis Z., Baca G. L., Boulter A., Bracken O. V., Bullock N., Champion N., Chan C., Couto-Parada X., Dieobi-Anene K., Feehan K., Figtree G., Figtree M. C., Finlay M., Forooghi N., Gibbons J. M., Griffiths P., Hamblin M., Howes L., Itua I., Jones M., Jardim V., Kapil V., Jason Lee W.-Y., Mandadapu V., Mfuko C., Mitchelmore O., Palma S., Patel K., Petersen S. E., Piniera B., Raine R., Rapala A., Richards A., Sambile G., Couto de Sousa J., Sugimoto M., Thornton G. D., Artico J., Zahedi D., Parker R., Robathan M., Hickling L. M., Ntusi N., Semper A., Brooks T., Jones J., Tucker A., Veerapen J., Vijayakumar M., Wodehouse T., Wynne L., Treibel T. A., Noursadeghi M., Manisty C., Moon J. C., Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19. Wellcome Open Res. 5, 179 (2020). 10.12688/wellcomeopenres.16051.2
- Reynolds C. J., Swadling L., Gibbons J. M., Pade C., Jensen M. P., Diniz M. O., Schmidt N. M., Butler D. K., Amin O. E., Bailey S. N. L., Murray S. M., Pieper F. P., Taylor S., Jones J., Jones M., Lee W. J., Rosenheim J., Chandran A., Joy G., Di Genova C., Temperton N., Lambourne J., Cutino-Moguel T., Andiapen M., Fontana M., Smit A., Semper A., O’Brien B., Chain B., Brooks T., Manisty C., Treibel T., Moon J. C., Noursadeghi M., Altmann D. M., Maini M. K., McKnight Á., Boyton R. J.; COVIDsortium investigators; COVIDsortium immune correlates network , Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. Sci. Immunol. 5, eabf3698 (2020). 10.1126/sciimmunol.abf3698
- Manisty C., Treibel T. A., Jensen M., Semper A., Joy G., Gupta R. K., Cutino-Moguel T., Andiapen M., Jones J., Taylor S., Otter A., Pade C., Gibbons J., Lee J., Bacon J., Thomas S., Moon C., Jones M., Williams D., Lambourne J., Fontana M., Altmann D. M., Boyton R., Maini M., McKnight A., Chain B., Noursadeghi M., Moon J. C., Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection. EBioMedicine 65, 103259 (2021). 10.1016/j.ebiom.2021.103259
- COVID-19 vaccines: Acting on the evidence. Nat. Med. 27, 183 (2021). 10.1038/s41591-021-01261-5
- Manisty C., Otter A. D., Treibel T. A., McKnight Á., Altmann D. M., Brooks T., Noursadeghi M., Boyton R. J., Semper A., Moon J. C., Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet 397, 1057–1058 (2021). 10.1016/S0140-6736(21)00501-8
- Shen X., Tang H., McDanal C., Wagh K., Fischer W., Theiler J., Yoon H., Li D., Haynes B. F., Sanders K. O., Gnanakaran S., Hengartner N., Pajon R., Smith G., Glenn G. M., Korber B., Montefiori D. C., SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines. Cell Host Microbe 29, 529–539.e3 (2021). 10.1016/j.chom.2021.03.002
- Greaney A. J., Loes A. N., Crawford K. H. D., Starr T. N., Malone K. D., Chu H. Y., Bloom J. D., Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463–476.e6 (2021). 10.1016/j.chom.2021.02.003
- Supasa P., Zhou D., Dejnirattisai W., Liu C., Mentzer A. J., Ginn H. M., Zhao Y., Duyvesteyn H. M. E., Nutalai R., Tuekprakhon A., Wang B., Paesen G. C., Slon-Campos J., López-Camacho C., Hallis B., Coombes N., Bewley K. R., Charlton S., Walter T. S., Barnes E., Dunachie S. J., Skelly D., Lumley S. F., Baker N., Shaik I., Humphries H. E., Godwin K., Gent N., Sienkiewicz A., Dold C., Levin R., Dong T., Pollard A. J., Knight J. C., Klenerman P., Crook D., Lambe T., Clutterbuck E., Bibi S., Flaxman A., Bittaye M., Belij-Rammerstorfer S., Gilbert S., Hall D. R., Williams M. A., Paterson N. G., James W., Carroll M. W., Fry E. E., Mongkolsapaya J., Ren J., Stuart D. I., Screaton G. R., Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell 184, 2201–2211.e7 (2021). 10.1016/j.cell.2021.02.033
- Muik A., Wallisch A. K., Sänger B., Swanson K. A., Mühl J., Chen W., Cai H., Maurus D., Sarkar R., Türeci Ö., Dormitzer P. R., Şahin U., Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science 371, 1152–1153 (2021). 10.1126/science.abg6105
- Reynolds C. J., Suleyman O. M., Ortega-Prieto A. M., Skelton J. K., Bonnesoeur P., Blohm A., Carregaro V., Silva J. S., James E. A., Maillère B., Dorner M., Boyton R. J., Altmann D. M., T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses. Sci. Rep. 8, 672 (2018). 10.1038/s41598-017-18781-1
- Krammer F., Srivastava K., Alshammary H., Amoako A. A., Awawda M. H., Beach K. F., Bermúdez-González M. C., Bielak D. A., Carreño J. M., Chernet R. L., Eaker L. Q., Ferreri E. D., Floda D. L., Gleason C. R., Hamburger J. Z., Jiang K., Kleiner G., Jurczyszak D., Matthews J. C., Mendez W. A., Nabeel I., Mulder L. C. F., Raskin A. J., Russo K. T., Salimbangon A. T., Saksena M., Shin A. S., Singh G., Sominsky L. A., Stadlbauer D., Wajnberg A., Simon V., Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N. Engl. J. Med. 384, 1372–1374 (2021). 10.1056/NEJMc2101667
- Bertoletti A., Tan A. T., Le Bert N., The T-cell response to SARS-CoV-2: Kinetic and quantitative aspects and the case for their protective role. Oxford Open Immunology 2, iqab006 (2021). 10.1093/oxfimm/iqab006
- Goel R. R., Apostolidis S. A., Painter M. M., Mathew D., Pattekar A., Kuthuru O., Gouma S., Hicks P., Meng W., Rosenfeld A. M., Dysinger S., Lundgreen K. A., Kuri-Cervantes L., Adamski S., Hicks A., Korte S., Oldridge D. A., Baxter A. E., Giles J. R., Weirick M. E., McAllister C. M., Dougherty J., Long S., D’Andrea K., Hamilton J. T., Betts M. R., Luning Prak E. T., Bates P., Hensley S. E., Greenplate A. R., Wherry E. J., Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination. Sci. Immunol. 6, eabi6950 (2021). 10.1126/sciimmunol.abi6950
- Public Health England, COVID-19: laboratory evaluations of serological assays, , 16 March 2021; .
- Peng Y., Mentzer A. J., Liu G., Yao X., Yin Z., Dong D., Dejnirattisai W., Rostron T., Supasa P., Liu C., López-Camacho C., Slon-Campos J., Zhao Y., Stuart D. I., Paesen G. C., Grimes J. M., Antson A. A., Bayfield O. W., Hawkins D. E. D. P., Ker D. S., Wang B., Turtle L., Subramaniam K., Thomson P., Zhang P., Dold C., Ratcliff J., Simmonds P., de Silva T., Sopp P., Wellington D., Rajapaksa U., Chen Y.-L., Salio M., Napolitani G., Paes W., Borrow P., Kessler B. M., Fry J. W., Schwabe N. F., Semple M. G., Baillie J. K., Moore S. C., Openshaw P. J. M., Ansari M. A., Dunachie S., Barnes E., Frater J., Kerr G., Goulder P., Lockett T., Levin R., Zhang Y., Jing R., Ho L.-P., Cornall R. J., Conlon C. P., Klenerman P., Screaton G. R., Mongkolsapaya J., McMichael A., Knight J. C., Ogg G., Dong T.; Oxford Immunology Network Covid-19 Response T cell Consortium; ISARIC4C Investigators , Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336–1345 (2020). 10.1038/s41590-020-0782-6
- GISAID, Tracking of variants; .
- Reynisson B., Alvarez B., Paul S., Peters B., Nielsen M., NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449–W454 (2020). 10.1093/nar/gkaa379
- Quigley K. J., Reynolds C. J., Goudet A., Raynsford E. J., Sergeant R., Quigley A., Worgall S., Bilton D., Wilson R., Loebinger M. R., Maillere B., Altmann D. M., Boyton R. J., Chronic infection by mucoid Pseudomonas aeruginosa associated with dysregulation in T-cell immunity to outer membrane porin F. Am. J. Respir. Crit. Care Med. 191, 1250–1264 (2015). 10.1164/rccm.201411-1995OC
- Reynolds C., Goudet A., Jenjaroen K., Sumonwiriya M., Rinchai D., Musson J., Overbeek S., Makinde J., Quigley K., Manji J., Spink N., Yos P., Wuthiekanun V., Bancroft G., Robinson J., Lertmemongkolchai G., Dunachie S., Maillere B., Holden M., Altmann D., Boyton R., T cell immunity to the alkyl hydroperoxide reductase of Burkholderia pseudomallei: A correlate of disease outcome in acute melioidosis. J. Immunol. 194, 4814–4824 (2015). 10.4049/jimmunol.1402862
Source: PubMed